Catalyst Wire Dossier Catalyst Wire Dossier

Omidria

phenylephrine/ketorolac intraocular solution · Omeros Corporation
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for Omidria, covering 2014-05-30 to 2024-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of Complication Rates in Cataract Surgery Patients Treated With Combined Pre-operative NSAID, OMIDRIA, and Subconjunctival Triamcinolone Acetonide Compared With Peri-operative SOC [Phase 1, Phase 2]

See pricing